Description
Danish Lung Pathologists Group, Danish Oncology Lung Cancer Group, Finnish Lung Cancer Group, Swedish Molecular Pathology Group, Swedish Society of Pathology, Swedish Lung Cancer Study Group and a Nordic Pathology Network steering committee. Cancer Academy North
Invites you to:
5th Nordic Pathology Meeting on Pathology & Biomarkers in thoracic malignancies, primarily NSCLC
Clarion Hotel Arlanda, Sweden – 31 January – 1 February 2019
Steering committee:
Birgit Guldhammer Skov (DK), Elisa Lappi-Blanco (FIN), Fredrik Enlund (S),
Lars Helgeland (NO), Jens Benn Sørensen (DK), Simon Ekman (S)
The objectives of the meeting are to highlight the latest developments – Pathology, Oncology and Technology. How can we use improved technology to advice on optimal treatments in lung cancer in a constantly changing environment? Please see preliminary program for the meeting.
Who should attend the meeting? Pathologists, Molecular biologists, Lung oncologists, Pulmonologists, and other interested in the field of Lung Cancer. Residents as well as consulting doctors should attend the meeting.
Language: English
Number of Participants: 150
Form of Symposium: Lectures and discussion
Registration Fee: 2000 SKR
Application deadline: January 15, 2019
What is included in the registration fee?
Admission to all scientific sessions
Admission to exhibition
Final Program
Coffee/tea during breaks
Lunch
Dinner January 31th
Hotel rooms during the meeting
Hotel rooms are pre-booked with discounted rate at Clarion Hotel Arlanda, (arrival January 31th for one night). Rooms and reduced price is guaranteed until November 30. After that date we can’t guarantee room or price.
For hotel booking – click here
NOTE! Hotel rooms are not included in the congress fee. The hotel rooms have to be booked and paid by each participant.
We hope that this will be an interesting and productive meeting and look forward to see you at Clarion Hotel Arlanda – Stockholm in January 2019.
A Warme Welcome
Steering committee
|
Birgit Guldhammer Skov (DK)
|
Elisa Lappi-Blanco (FIN)
|
Fredrik Enlund (S)
|
|
Lars Helgeland (NO)
|
Jens Benn Sørensen (DK)
|
Simon Ekman (S)
|
If you have any questions – please contact Monica Sandström, tel: +46 90 – 785 28 55, e-mail: monica.sandstrom@umu.se
Program
|
January 31
|
|
|
|
IO and biomarkers - Birgit Guldhammer Skov, Denmark
|
|
10.00 - 10.10
|
Welcome to the meeting
|
|
|
10.10 - 10.40
|
PD-L1 as a biomarker for IO in NSCLC
|
Keith Kerr, UK
|
|
10.45 - 11.15
|
PD-L1 on cytology
|
Birgit Guldhammer Skov, DK
|
|
11.15 – 11.45
|
Coffee break/exhibition
|
|
|
11.45 – 12.15
|
PD-L1 - NordiQC experiences
|
Mogens Vyberg, DK
|
|
12.15 - 12.30
|
Discussions of the morning sessions
|
Birgit Guldhammer Skov, DK
|
|
12.30 – 13.30
|
Lunch
|
|
|
13.30 – 14.00
|
Other biomarker for IO, including TMB
|
Keith Kerr, UK
|
|
14.05 – 14.35
|
PD-L1 prevalence in an unselected (Danish) population
|
Birgit Guldhammer Skov, DK
|
|
14.35 – 15.00
|
Coffee break/Exhibition
|
|
|
|
|
|
|
Oncogenic drivers and technologies - Simon Ekman, Fredrik Enlund, Sweden
|
|
15.00 – 15.30
|
Clinical aspects of fusion genes in NSCLC
|
Jussi Koivunen, FI
|
|
15.35 – 16.05
|
Molecular analyses of fusion genes
|
Fredrik Enlund, SE
|
|
16.05 – 16.15
|
Questions and answers
|
|
|
16.15 – 16.35
|
Short break
|
|
|
16.35 – 17.00
|
Targets beyond EGFR and ALK in NSCLC
|
Simon Ekman, SE
|
|
17.00 – 17.30
|
What to report and not to report in the molecular pathology report
|
Johan Botling, SE
|
|
17.30 – 17.40
|
Wrap-up
|
Simon Ekman SE, Fredrik Enlund, SE
|
|
19.00 -
|
Dinner
|
|
|
|
|
February 1
|
|
|
|
Oncogenic drivers and technologies - Simon Ekman, Fredrik Enlund, Sweden
|
|
08.00 – 08.25
|
An update on the use of EGFR TKIs in NSCLC
|
Odd Terje Brustugun, NO
|
|
08.30 – 08:50
|
Liquid biopsies in EGFR-mutation positive patients – when to use it and which methods
|
Juha Kononen, FI
|
|
08.50 – 09.05
|
Rebiopsy in EGFR TKI treated patients – when and how?
|
Juha Kononen, FI
|
|
09.05 – 09.20
|
Coffee break/Exhibition
|
|
|
09.20 – 10.00
|
Breakout sessions countrywise
|
|
|
10.00 – 10.20
|
Coffee break/Exhibition
|
|
|
|
|
|
|
MPM and SCLC – Jens Benn Sørensen, Denmark
|
|
10.20 – 10.50
|
Status on IO in MPM and SCLC (Clinical)
|
Jens Benn Sørensen, DK
|
|
10.50 – 11.20
|
Delta-like protein 3 (DLL3) ADC in SCLC - (Rova-T)
|
Seppo Langer, DK
|
|
11.20 – 11.50
|
MPM prognostic markers and potential therapeutic targets
|
Oluf Dimitri Røe, NO
|
|
11.50 – 12.25
|
Subtyping of Malignant Mesothelioma including reproducibility of biphasic mesothelioma: Data from the MESOPATH reference center
|
Francoise Galateau-Sallé, F
|
|
12.25 – 12.55
|
Genomic Medicin Sweden (GMS) and its implication on biomarker analysis in lung cancer
|
Richard Rosenquist Brandell
|
|
12.55 – 13.10
|
Discussion and Close up!
|
Organizing Committee
|
|
13.10 – 14.10
|
Lunch
|
|
The meeting is sponsored by:
